Eliem Therapeutics Inc (NASDAQ: ELYM) Stock Information | RedChip

Eliem Therapeutics Inc (NASDAQ: ELYM) Listen to this Section


$6.09
N/A ( 0% ) 124.0K

Eliem Therapeutics Inc is a clinical-stage biotechnology company. It is focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems. Its main drug candidate is ETX-155 for major depressive disorder (MDD) and focal onset seizures (FOS).

Market Data


Open


$6.09

Previous close


$6.09

Volume


124.0K

Market cap


$412.42M

Day range


$5.93 - $6.26

52 week range


$2.35 - $11.55

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
10-k Annual reports 73 Mar 28, 2024
4 Insider transactions 1 Mar 20, 2024
8-k 8K-related 15 Mar 19, 2024
4 Insider transactions 1 Mar 04, 2024
10-q Quarterly Reports 57 Nov 14, 2023
10-q Quarterly Reports 58 Aug 10, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.